CD40.PCA

N/A

Report date: 2025/04/18 15:19:27

Base Information

Drug NameCD40.PCA

Drug Alias NameCD40.PCA

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized

Mechanisms of ActionAnti-CD40

TargetsTumor necrosis factor receptor superfamily member 5

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLinKinVax

China Registration ClassN/A

Active CompaniesLinKinVax

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A